1. Home
  2. TOI vs PACB Comparison

TOI vs PACB Comparison

Compare TOI & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOI
  • PACB
  • Stock Information
  • Founded
  • TOI 2007
  • PACB 2000
  • Country
  • TOI United States
  • PACB United States
  • Employees
  • TOI N/A
  • PACB N/A
  • Industry
  • TOI Medical/Nursing Services
  • PACB Biotechnology: Laboratory Analytical Instruments
  • Sector
  • TOI Health Care
  • PACB Industrials
  • Exchange
  • TOI Nasdaq
  • PACB Nasdaq
  • Market Cap
  • TOI 393.4M
  • PACB 369.5M
  • IPO Year
  • TOI N/A
  • PACB 2010
  • Fundamental
  • Price
  • TOI $3.82
  • PACB $1.64
  • Analyst Decision
  • TOI Strong Buy
  • PACB Buy
  • Analyst Count
  • TOI 1
  • PACB 7
  • Target Price
  • TOI $6.00
  • PACB $1.90
  • AVG Volume (30 Days)
  • TOI 1.8M
  • PACB 7.4M
  • Earning Date
  • TOI 11-12-2025
  • PACB 11-06-2025
  • Dividend Yield
  • TOI N/A
  • PACB N/A
  • EPS Growth
  • TOI N/A
  • PACB N/A
  • EPS
  • TOI N/A
  • PACB N/A
  • Revenue
  • TOI $424,376,000.00
  • PACB $156,110,000.00
  • Revenue This Year
  • TOI $21.71
  • PACB $6.17
  • Revenue Next Year
  • TOI $20.58
  • PACB $15.63
  • P/E Ratio
  • TOI N/A
  • PACB N/A
  • Revenue Growth
  • TOI 17.53
  • PACB N/A
  • 52 Week Low
  • TOI $0.13
  • PACB $0.85
  • 52 Week High
  • TOI $4.50
  • PACB $2.72
  • Technical
  • Relative Strength Index (RSI)
  • TOI 55.58
  • PACB 61.86
  • Support Level
  • TOI $3.79
  • PACB $1.37
  • Resistance Level
  • TOI $4.24
  • PACB $1.84
  • Average True Range (ATR)
  • TOI 0.25
  • PACB 0.12
  • MACD
  • TOI 0.02
  • PACB 0.03
  • Stochastic Oscillator
  • TOI 54.02
  • PACB 69.67

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Share on Social Networks: